Free Trial

MoonLake Immunotherapeutics (MLTX) SEC Filings & 10K Form

MoonLake Immunotherapeutics logo
$49.82 +0.49 (+0.99%)
(As of 11/20/2024 ET)

Recent MoonLake Immunotherapeutics SEC Filings

DateFilerForm TypeView
11/07/2024
6:03 AM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
6:05 AM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/08/2024
5:48 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
MoonLake Immunotherapeutics (Subject)
MoonLake Immunotherapeutics (Subject)
Form SC 13D/A
10/08/2024
5:50 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:30 AM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
7:02 AM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
7:04 AM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/10/2024
4:06 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:40 PM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
6:30 AM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
7:01 AM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
7:02 AM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
6:57 AM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 10-K/A
04/24/2024
3:30 PM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form DEF 14A
04/24/2024
3:31 PM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form DEFA14A
04/24/2024
3:33 PM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form ARS
03/11/2024
7:01 AM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
6:53 PM
MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
Reich Kristian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
6:56 PM
MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
Santos da Silva Jorge (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
7:03 AM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
7:05 AM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2024
8:00 AM
MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
5:32 PM
MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
Reich Kristian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
5:36 PM
MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
Santos da Silva Jorge (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
5:02 PM
MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
Reich Kristian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
7:00 AM
Merck Healthcare KGaA (Filed by)
MoonLake Immunotherapeutics (Subject)
MoonLake Immunotherapeutics (Subject)
Form SC 13G/A
02/14/2024
3:57 PM
CITADEL ADVISORS LLC (Filed by)
MoonLake Immunotherapeutics (Subject)
MoonLake Immunotherapeutics (Subject)
Form SC 13G/A
02/09/2024
8:28 AM
FMR LLC (Filed by)
MoonLake Immunotherapeutics (Subject)
MoonLake Immunotherapeutics (Subject)
Form SC 13G
12/20/2023
3:16 PM
Bodenstedt Matthias (Reporting)
MoonLake Immunotherapeutics (Subject)
MoonLake Immunotherapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/19/2023
3:34 PM
Bodenstedt Matthias (Reporting)
MoonLake Immunotherapeutics (Subject)
MoonLake Immunotherapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MLTX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners